Progestins activate 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3) in breast cancer cells

Biochemical Journal

Volumn 442, Issue 2, 2012, Pages 345-356

  Novellasdemunt, Laura ^a   Obach, Mercè ^a   Millán ariño, Lluís ^b   Manzano, Anna ^a   Ventura, Francesc ^a   Rosa, Jose Luis ^a   Jordan, Albert ^b   Navarro Sabate, Àurea ^a   Bartrons, Ramon ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUT DE BIOLOGIA MOLECULAR DE BARCELONA   (Spain)

Author keywords

6 bisphosphatase (PFKFB3); 6 phosphofructo 2 kinase fructose 2; Breast cancer; Gene regulation; Glycolysis; Metabolism; Progestins

Indexed keywords

16ALPHA ETHYL 21 HYDROXY 19 NORPREGN 4 ENE 3,20 DIONE; 6 PHOSPHOFRUCTO 2 KINASE; FRUCTOSE 2,6 BISPHOSPHATASE; MITOGEN ACTIVATED PROTEIN KINASE; NORGESTREL; PROGESTERONE RECEPTOR; S6 KINASE;

ARTICLE; BREAST CANCER; CANCER CELL; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GENE; GENE CONTROL; GENE EXPRESSION; GENE INDUCTION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GLYCOLYSIS; HUMAN; HUMAN CELL; PFKFB3 GENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; REGULATORY MECHANISM; WESTERN BLOTTING;

BASE SEQUENCE; BREAST NEOPLASMS; CELL LINE, TUMOR; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAP KINASE SIGNALING SYSTEM; NORGESTREL; PHOSPHOFRUCTOKINASE-2; PREGNENEDIONES; PROGESTERONE CONGENERS; PROMOTER REGIONS, GENETIC; RECEPTORS, PROGESTERONE; RNA, MESSENGER; RNA, NEOPLASM;

EID: 84856877500     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20111418     Document Type: Article

References (51)

1. Gao, X. and Nawaz, Z. (2002) Progesterone receptors - animal models and cell signaling in breast cancer: role of steroid receptor coactivators and corepressors of progesterone receptors in breast cancer. Breast Cancer Res. 4, 182-186 (Pubitemid 34918995)
2. Lange, C. A., Gioeli, D., Hammes, S. R. and Marker, P. C. (2007) Integration of rapid signaling events with steroid hormone receptor action in breast and prostate cancer. Annu. Rev. Physiol. 69, 171-199 (Pubitemid 46457640)
3. Vicent, G. P., Ballaré, C., Nacht, A. S., Clausell, J., Subtil-Rodríguez, A., Quiles, I., Jordan, A. and Beato, M. (2006) Induction of progesterone target genes requires activation of Erk and Msk kinases and phosphorylation of histone H3. Mol. Cell 24, 367-381 (Pubitemid 44649285)
4. Daniel, A. R., Knutson, T. P. and Lange, C. A. (2009) Signaling inputs to progesterone receptor gene regulation and promoter selectivity. Mol. Cell. Endocrinol. 308, 47-52
5. Owen, G. I., Richer, J. K., Tung, L., Takimoto, G. and Horwitz, K. B. (1998) Progesterone regulates transcription of the p21 (WAF1) cyclin-dependent kinase inhibitor gene through Sp1 and CBP/p300. J. Biol. Chem. 273, 10696-10701 (Pubitemid 28227684)
6. Proietti, C., Salatino, M., Rosemblit, C., Carnevale, R., Pecci, A., Kornblihtt, A. R., Molinolo, A. A., Frahm, I., Charreau, E. H., Schillaci, R. et al. (2005) Progestins induce transcriptional activation of signal transducer and activator of transcription 3 (Stat3) via a Jak- and Src-dependent mechanism in breast cancer cells. Mol. Cell. Biol. 25, 4826-4840 (Pubitemid 40781085)
7. Richer, J. K., Jacobsen, B. M., Manning, N. G., Abel, M. G., Wolf, D. M. and Horwitz, K. B. (2002) Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells. J. Biol. Chem. 277, 5209-5218 (Pubitemid 34968565)
8. Tseng, L., Tang, M., Wang, Z. and Mazella, J. (2003) Progesterone receptor (hPR) upregulates the fibronectin promoter activity in human decidual fibroblasts. DNA Cell Biol. 22, 633-640 (Pubitemid 37357733)
9. Migliaccio, A., Piccolo, D., Castoria, G., Di Domenico, M., Bilancio, A., Lombardi, M., Gong, W., Beato, M. and Auricchio, F. (1998) Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor. EMBO J. 17, 2008-2018 (Pubitemid 28154530)
10. Vicent, G. P., Nacht, A. S., Zaurín, R., Ballaré, C., Clausell, J. and Beato, M. (2010) Minireview: role of kinases and chromatin remodeling in progesterone signaling to chromatin. Mol. Endocrinol. 24, 2088-2098
11. Moore, N. L., Narayanan, R. and Weigel, N. L. (2007) Cyclin dependent kinase 2 and the regulation of human progesterone receptor activity. Steroids 72, 202-209 (Pubitemid 46273504)
12. Chalbos, D., Haagensen, D., Parish, T. and Rochefort, H. (1987) Identification and androgen regulation of two proteins released by T47D human breast cancer cells. Cancer Res. 47, 2787-2792
13. Faivre, E., Skildum, A., Pierson-Mullany, L. and Lange, C. A. (2005) Integration of progesterone receptor mediated rapid signaling and nuclear actions in breast cancer cell models: role of mitogen-activated protein kinases and cell cycle regulators. Steroids 70, 418-426 (Pubitemid 40616040)
14. Subtil-Rodriguez, A., Millán-Ariño, L., Quiles, I., Ballaré, C., Beato, M. and Jordan, A. (2008) Progesterone induction of the 11β-hydroxysteroid dehydrogenase type 2 promoter in breast cancer cells involves coordinated recruitment of STAT5A and progesterone receptor to a distal enhancer and polymerase tracking. Mol. Cell. Biol. 28, 3830-3849 (Pubitemid 351732916)
15. Wade, H. E., Kobayashi, S., Eaton, M. L., Jansen, M. S., Lobenhofer, E. K., Lupien, M., Geistlinger, T. R., Zhu, W., Nevins, J. R., Brown, M. et al. (2010) Multimodal regulation of E2F1 gene expression by progestins. Mol. Cell. Biol. 30, 1866-1877
16. Quiles, I., Millán-Ariño, L., Subtil-Rodríguez, A., Miñana, B., Spinedi, N., Ballaré, C., Beato, M. and Jordan, A. (2009) Mutational analysis of progesterone receptor functional domains in stable cell lines delineates sets of genes regulated by different mechanisms. Mol. Endocrinol. 23, 809-826
17. Hamilton, J. A., Callaghan, M. J., Sutherland, R. L. and Watts, C. K. (1997) Identification of PRG1, a novel progestin-responsive gene with sequence homology to 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase. Mol. Endocrinol. 11, 490-502 (Pubitemid 27147017)
18. Ventura, F., Ambrosio, S., Bartrons, R., el-Maghrabi, M. R., Lange, A. J. and Pilkis, S. J. (1995) Cloning and expression of a catalytic core bovine brain 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase. Biochem. Biophys. Res. Commun. 209, 1140-1148
19. Manzano, A., Rosa, J. L., Ventura, F., Pérez, J. X., Nadal, M., Estivill, X., Ambrosio, S., Gil, J. and Bartrons, R. (1998) Molecular cloning, expression, and chromosomal localization of a ubiquitously expressed human 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase gene (PFKFB3). Cytogenet. Cell Genet. 83, 214-217 (Pubitemid 29112740)
20. Chesney, J., Mitchell, R., Benigni, F., Bacher, M., Spiege, L., Al-Abed, Y., Han, J. H., Metz, C. and Bucala, R. (1999) An inducible gene product for 6-phosphofructo-2-kinase with an AU-rich instability element: role in tumor cell glycolysis and the Warburg effect. Proc. Natl. Acad. Sci. U.S.A. 96, 3047-3052 (Pubitemid 29148841)
21. Van Schaftingen, E. (1987) Fructose-2,6-bisphosphate. Adv. Enzymol. Relat. Areas Mol. Biol. 59, 315-395
22. Rider, M. H., Bertrand, L., Vertommen, D., Michels, P. A., Rousseau, G. G. and Hue, L. (2004) 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase: head-to-head with a bifunctional enzyme that controls glycolysis. Biochem. J. 381, 561-579 (Pubitemid 39120464)
23. Okar, D. A., Manzano, A., Navarro-Sabaté, A., Riera, L., Bartrons, R. and Lange, A. J. (2001) PFK-2/FBPase-2: maker and breaker of the essential biofactor fructose-2,6-bisphosphate. Trends Biochem. Sci. 26, 30-35 (Pubitemid 32124707)
24. Bartrons, R. and Caro, J. (2007) Hypoxia, glucose metabolism and the Warburg's effect. J. Bioenerg. Biomembr. 39, 223-229 (Pubitemid 47619374)
25. Sakakibara, R., Uemura, M., Hirata, T., Okamura, N. and Kato, M. (1997) Human placental fructose-6-phosphate,2-kinase/fructose-2,6-bisphosphatase: its isozymic form, expression and characterization. Biosci. Biotechnol. Biochem. 61, 1949-1952 (Pubitemid 127471802)
26. Riera, L., Manzano, A., Navarro-Sabaté, A., Perales, J. C. and Bartrons, R. (2002) Insulin induces PFKFB3 gene expression in HT29 human colon adenocarcinoma cells. Biochim. Biophys. Acta 1589, 89-92 (Pubitemid 34463076)
27. Obach, M., Navarro-Sabaté, A., Caro, J., Kong, X., Duran, J., Gómez, M., Perales, J. C., Ventura, F., Rosa, J. L. and Bartrons, R. (2004) 6-Phosphofructo-2-kinase (pfkfb3) gene promoter contains hypoxia-inducible factor-1 binding sites necessary for transactivation in response to hypoxia. J. Biol. Chem. 279, 53562-53570 (Pubitemid 40051863)
28. Duran, J., Navarro-Sabaté, A., Pujol, A., Perales, J. C., Manzano, A., Obach, M., Gómez, M. and Bartrons, R. (2008) Overexpression of ubiquitous 6-phosphofructo-2-kinase in the liver of transgenic mice results in weight gain. Biochem. Biophys. Res. Commun. 365, 291-297 (Pubitemid 350148073)
29. Duran, J., Obach, M., Navarro-Sabaté, A., Manzano, A., Gómez, M., Rosa, J. L., Ventura, F., Perales, J. C. and Bartrons, R. (2009) Pfkfb3 is transcriptionally upregulated in diabetic mouse liver through proliferative signals. FEBS J. 276, 4555-4568
30. Yalcin, A., Telang, S., Clem, B. and Chesney, J. (2009) Regulation of glucose metabolism by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases in cancer. Exp. Mol. Pathol. 86, 174-179
31. Almeida, A., Bolaños, J. P. and Moncada, S. (2010) E3 ubiquitin ligase APC/C-Cdh1 accounts for the Warburg effect by linking glycolysis to cell proliferation. Proc. Natl. Acad. Sci. U.S.A. 107, 738-741
32. Calvo, M. N., Bartrons, R., Castaño, E., Perales, J. C., Navarro-Sabaté, A. and Manzano, A. (2006) PFKFB3 gene silencing decreases glycolysis, induces cell-cycle delay and inhibits anchorage-independent growth in HeLa cells. FEBS Lett. 580, 3308-3314 (Pubitemid 44251000)
33. Atsumi, T., Chesney, J., Metz, C., Leng, L., Donnelly, S., Makita, Z., Mitchell, R. and Bucala, R. (2002) High expression of inducible 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (iPFK-2; PFKFB3) in human cancers. Cancer Res. 62, 5881-5887 (Pubitemid 35204749)
34. Kessler, R., Bleichert, F., Warnke, J. P. and Eschrich, K. (2008) 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFKFB3) is up-regulated in high-grade astrocytomas. J. Neurooncol. 86, 257-264
35. Van Schaftingen, E., Lederer, B., Bartrons, R. and Hers, H. G. (1982) A kinetic study of pyrophosphate: fructose-6-phosphate phosphotransferase from potato tubers. Application to a microassay of fructose 2,6-bisphosphate. Eur. J. Biochem. 129, 191-195
36. Gutmann, I. and Wahlefeld, A. W. (1974) I-(+)-Lactate. In Methods of Enzymatic Analysis (Bergmeyer, H. U., ed.), pp. 1464-1468, Academic Press, New York
37. Sancho, M., Diani, E., Beato, M. and Jordan, A. (2008) Depletion of human histone H1 variants uncovers specific roles in gene expression and cell growth. PLoS Genet. 4, e1000227
38. Silverman, E., Frödin, M., Gammeltoft, S. and Maller, J. L. (2004) Activation of p90 Rsk1 is sufficient for differentiation of PC12 cells. Mol. Cell. Biol. 24, 10573-10583 (Pubitemid 39603117)
39. Horwitz, K. B. and McGuire, W. L. (1978) Nuclear mechanisms of estrogen action. Effects of estradiol and anti-estrogens on estrogen receptors and nuclear receptor processing. J. Biol. Chem. 253, 8185-8191 (Pubitemid 9086303)
40. Leighton, I. A., Dalby, K. N., Caudwell, F. B., Cohen, P. T. and Cohen, P. (1995) Comparison of the specificities of p70 S6 kinase and MAPKAP kinase-1 identifies a relatively specific substrate for p70 S6 kinase: the N-terminal kinase domain of MAPKAP kinase-1 is essential for peptide phosphorylation. FEBS Lett. 375, 289-293
41. Sapkota, G. P., Cummings, L., Newell, F. S., Armstrong, C., Bain, J., Frodin, M., Grauert, M., Hoffmann, M., Schnapp, G., Steegmaier, M. et al. (2007) BI-D1870 is a specific inhibitor of the p90 RSK (ribosomal S6 kinase) isoforms in vitro and in vivo. Biochem. J. 401, 29-38 (Pubitemid 46114597)
42. Graham, J. D., Yeates, C., Balleine, R. L., Harvey, S. S., Milliken, J. S., Bilous, A. M. and Clarke, C. L. (1995) Characterization of progesterone receptor A and B expression in human breast cancer. Cancer Res. 55, 5063-5068
43. Bando, H., Atsumi, T., Nishio, T., Niwa, H., Mishima, S., Shimizu, C., Yoshioka, N., Bucala, R. and Koike, T. (2005) Phosphorylation of the 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase/PFKFB3 family of glycolytic regulators in human cancer. Clin. Cancer Res. 11, 5784-5792 (Pubitemid 41170304)
44. Marsin, A. S., Bouzin, C., Bertrand, L. and Hue, L. (2002) The stimulation of glycolysis by hypoxia in activated monocytes is mediated by AMP-activated protein kinase and inducible 6-phosphofructo-2-kinase. J. Biol. Chem. 277, 30778-30783 (Pubitemid 34970775)
45. Marsin, A. S., Bertrand, L., Rider, M. H., Deprez, J., Beauloye, C., Vincent, M. F., Van der Berche, G., Carling, D. and Hue, L. (2000) Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia. Curr. Biol. 10, 1247-1255
46. Deprez, J., Vertommen, D., Alessi, D. R., Hue, L. and Rider, M. H. (1997) Phosphorylation and activation of heart 6-phosphofructo-2-kinase by protein kinase B and other protein kinases of the insulin signaling cascades. J. Biol. Chem. 272, 17269-17275 (Pubitemid 27311150)
47. Rider, M. H., van Damme, J., Vertommen, D., Michel, A., Vandekerckhove, J. and Hue, L. (1992) Evidence for new phosphorylation sites for protein kinase C and cyclic AMP-dependent protein kinase in bovine heart 6-phosphofructo-2- kinase/ fructose-2,6-bisphosphatase. FEBS Lett. 310, 139-142
48. Bertrand, L., Alessi, D. R., Deprez, J., Deak, M., Viaene, E., Rider, M. H. and Hue, L. (1999) Heart 6-phosphofructo-2-kinase activation by insulin results from Ser-466 and Ser-483 phosphorylation and requires 3-phosphoinositide-dependent kinase-1, but not protein kinase B. J. Biol. Chem. 274, 30927-30933
49. Moore, M. R., Zhou, J. L., Blankenship, K. A., Strobl, J. S., Edwards, D. P. and Gentry, R. N. (1997) A sequence in the 5′ flanking region confers progestin responsiveness on the human c-myc gene. J. Steroid Biochem. Mol. Biol. 62, 243-252 (Pubitemid 27504755)
50. Riera, L., Obach, M., Navarro-Sabaté, A., Duran, J., Perales, J. C., Viñals, F., Rosa, J. L., Ventura, F. and Bartrons, R. (2003) Regulation of ubiquitous 6-phosphofructo-2-kinase by the ubiquitin-proteasome proteolytic pathway during myogenic C2C12 cell differentiation. FEBS Lett. 550, 23-29 (Pubitemid 37281351)
51. Yalcin, A., Clem, B. F., Simmons, A., Lane, A., Nelson, K., Clem, A. L., Brock, E., Siow, D., Wattenberg, B., Telang, S. et al. (2009) Nuclear targeting of 6-phosphofructo-2-kinase (PFKFB3) increases proliferation via cyclin-dependent kinases. J. Biol. Chem. 284, 24223-24232